M
MEDU LABORATORIES
Vendor Ledger/Yiwu Aozuo Trading Co
Y

Yiwu Aozuo Trading Co

AExcellent 41 products · 168 certificates

Products examined

ProductRating Samples Avg MinMaxLatest
Ipamorelin A 6 8.6 6.5 10.0 9 Jun 2025
Semaglutide A 2 8.8 8.0 9.7 30 Dec 2025
Retatrutide C 26 8.2 4.9 10.0 4 Aug 2025
GHK-Cu C 9 7.8 4.9 9.9 4 Sep 2025
Cagrilintide C 6 6.9 4.8 8.0 28 Jun 2025
Tirzepatide C 24 7.6 4.4 10.0 9 Jun 2025
Tesamorelin D 7 7.8 3.3 10.0 9 Sep 2025
BPC-157 E 11 7.0 1.9 9.8 29 Jun 2025
1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 A 7 8.4 6.0 10.0 19 Jan 2026
5-amino-1MQ X 1 4.9 4.9 4.9 2 Apr 2025
ACE-031 A 9 7.8 5.8 9.4 21 May 2026
AHK-CU A 6 7.5 5.7 9.0 19 Jan 2026
Anastrozole (Arimidex) Raw A 7 7.9 7.1 9.0 17 May 2026
Andarine S4 A 7 7.8 4.6 9.9 21 May 2026
APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 A 4 7.5 5.7 8.6 19 Jan 2026
ARA-290 A 5 8.2 6.3 10.0 24 May 2026
Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) A 2 9.7 9.5 9.9 21 May 2026
BPC157 10mg + TB500 10mg Blend A 7 8.7 6.2 9.8 23 May 2026
BPC157 5mg + TB500 5mg Blend A 2 7.1 5.9 8.3 19 Jan 2026
Cagrilintide 5mg + Semaglutide 5mg Blend A 9 8.1 5.9 10.0 25 May 2026
Cartalax A 2 7.5 6.6 8.5 25 May 2026
Cerebrolysin A 2 8.2 7.4 8.9 19 Jan 2026
Drostanolone Propionate (Mast P) Raw A 9 7.9 6.3 9.8 21 May 2026
EPO A 4 7.2 5.8 8.1 23 May 2026
GW-501516 (Cardarine) X 1 5.4 5.4 5.4 21 May 2025
Hyaluronic acid A 2 8.8 8.3 9.3 20 May 2026
IGF-1 LR3 A 8 7.0 5.7 9.6 24 May 2026
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg A 8 8.2 5.5 10.0 25 May 2026
L-Carnitine 500mg A 2 7.9 5.9 9.8 26 Jan 2026
MT-1 A 4 9.1 8.6 10.0 24 May 2026
Phenylacetic acid CAS 103-82-2 A 8 8.2 6.9 10.0 21 May 2026
Pinealon A 7 9.0 6.6 10.0 24 May 2026
Primobolan E Raw A 5 7.9 6.1 9.4 20 May 2026
PTD-DBM A 5 6.9 5.2 8.1 24 May 2026
Retatrutide 30mg Pen Kit A 6 8.5 7.1 9.6 25 May 2026
Retatrutide 5mg + Cagrilintide 5mg Blend A 4 6.9 6.1 8.6 25 May 2026
S-23 Raw X 1 7.6 7.6 7.6 14 Jan 2025
SNAP-8 A 8 7.8 4.2 10.0 25 May 2026
SS-31 A 5 8.3 7.9 9.3 19 Jan 2026
Tesamorelin 11mg + Ipamorelin 6mg Blend X 1 5.8 5.8 5.8 8 Jul 2025
Vesugen A 3 7.6 6.6 8.5 25 May 2026

The certificates

DateProductScoreDeclared MeasuredDeviationPurityLaboratory
25 May 2026 GHK-Cu 7.1 50mg 47.3mg -5.4% 99.60% No Label / Silver Crimp / Blue Cap
25 May 2026 5-amino-1MQ 4.0 2mg 2.3mg +12.5% 98.38% Lab F
25 May 2026 Andarine S4 7.9 10mg 9.8mg -1.9% 99.23% Lab G
25 May 2026 Cagrilintide 5mg + Semaglutide 5mg Blend 8.0 50mg 55.0mg +9.9% 95.73% Lab F
25 May 2026 PTD-DBM 6.2 5mg 4.8mg -4.6% 99.38% Lab A
25 May 2026 SNAP-8 8.0 10mg 10.9mg +9.4% 99.00% Lab A
24 May 2026 Andarine S4 6.2 25mg 28.5mg +14.0% 98.34% Lab E
24 May 2026 APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 8.5 500g 584.4g +16.9% 99.22% Lab C
24 May 2026 Cartalax 7.5 10mg 8.6mg -14.4% 97.80% Lab A
24 May 2026 Phenylacetic acid CAS 103-82-2 7.6 5g 5.9g +17.5% 98.07% Lab C
24 May 2026 BPC157 5mg + TB500 5mg Blend 7.1 10mg 11.8mg +18.4% 95.36% Lab D
24 May 2026 MT-1 9.1 50mg 47.3mg -5.5% 97.38% Lab B
24 May 2026 Phenylacetic acid CAS 103-82-2 8.5 100g 92.9g -7.1% 96.71% Lab G
24 May 2026 Pinealon 8.1 20mg 19.8mg -0.9% 98.49% Lab G
24 May 2026 SNAP-8 7.6 5mg 6.1mg +22.2% 98.76% Lab A
24 May 2026 ARA-290 9.4 50mg 56.1mg +12.3% 99.08% Lab B
24 May 2026 BPC157 10mg + TB500 10mg Blend 10.0 30mg 31.6mg +5.4% 95.62% Lab G
24 May 2026 Cagrilintide 5mg + Semaglutide 5mg Blend 5.2 5mg 4.3mg -14.6% 98.35% Lab C
24 May 2026 EPO 6.5 15mg 14.4mg -3.8% 98.43% Lab A
24 May 2026 IGF-1 LR3 6.1 30mg 28.8mg -3.9% 99.29% Lab A
24 May 2026 SS-31 8.8 2mg 2.5mg +23.8% 95.65% Lab F
24 May 2026 Ipamorelin 9.5 10mg 10.1mg +1.0% 99.70% Black Label / Silver Crimp / Clear Green Cap
24 May 2026 Andarine S4 7.5 100mg 122.2mg +22.2% 98.90% Lab A
24 May 2026 Andarine S4 7.4 20mg 17.2mg -14.2% 95.81% Lab E
24 May 2026 Drostanolone Propionate (Mast P) Raw 9.3 5g 5.9g +18.7% 97.87% Lab B
24 May 2026 SNAP-8 5.1 5mg 5.3mg +5.7% 95.55% Lab A
24 May 2026 SNAP-8 7.3 10mg 9.8mg -1.8% 95.23% Lab G
24 May 2026 Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) 8.5 250mg/ml 232.4mg/ml -7.0% 97.36% Lab C
23 May 2026 Retatrutide 6.7 20mg 19.4mg -3.0% 99.36% No Label / Gold Crimp / Clear Cap
23 May 2026 Retatrutide 9.0 30mg 32.1mg +7.0% 99.77% White Label / Silver Crimp / Blue Cap
23 May 2026 Retatrutide 7.4 15mg 14.5mg -3.3% 98.44% White Label / Silver Crimp / Orange Cap
23 May 2026 Drostanolone Propionate (Mast P) Raw 8.0 1g 1.2g +21.0% 98.44% Lab G
23 May 2026 Drostanolone Propionate (Mast P) Raw 8.2 5g 5.3g +6.4% 95.73% Lab F
23 May 2026 Hyaluronic acid 9.5 20mg 24.6mg +22.9% 95.99% Lab A
23 May 2026 Hyaluronic acid 8.5 30mg 33.3mg +10.8% 96.48% Lab F
23 May 2026 SNAP-8 7.7 30mg 30.7mg +2.4% 98.93% Lab G
23 May 2026 Tesamorelin 11mg + Ipamorelin 6mg Blend 6.2 50mg 59.2mg +18.4% 96.01% Lab D
23 May 2026 Tirzepatide 9.7 60mg 58.2mg -3.0% 99.76% No Label / Silver Crimp / Orange Cap
23 May 2026 Tirzepatide 10.0 60mg 62.9mg +4.8% 99.88% No Label / Silver Crimp / Orange Cap
23 May 2026 ACE-031 7.9 10mg 12.1mg +20.8% 98.87% Lab A
23 May 2026 ACE-031 7.2 50mg 59.2mg +18.4% 97.72% Lab F
23 May 2026 BPC157 5mg + TB500 5mg Blend 8.1 50mg 60.8mg +21.6% 97.80% Lab G
23 May 2026 IGF-1 LR3 8.3 2mg 2.0mg +2.1% 98.27% Lab F
23 May 2026 MT-1 9.2 2mg 1.9mg -3.2% 98.23% Lab F
23 May 2026 Phenylacetic acid CAS 103-82-2 6.6 10g 11.4g +14.2% 99.01% Lab E
21 May 2026 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 7.5 5g 4.7g -5.9% 97.48% Lab D
21 May 2026 ARA-290 9.4 30mg 30.5mg +1.7% 99.53% Lab D
21 May 2026 BPC157 10mg + TB500 10mg Blend 8.4 50mg 52.6mg +5.2% 96.73% Lab F
21 May 2026 Drostanolone Propionate (Mast P) Raw 9.8 5g 4.5g -9.5% 98.38% Lab E
21 May 2026 Pinealon 10.0 10mg 9.3mg -7.2% 97.65% Lab G
21 May 2026 Pinealon 9.7 30mg 32.3mg +7.7% 97.03% Lab F
21 May 2026 Retatrutide 30mg Pen Kit 9.3 10mg 11.9mg +18.7% 97.79% Lab B
21 May 2026 ARA-290 8.6 10mg 11.7mg +17.0% 96.62% Lab F
21 May 2026 Primobolan E Raw 7.4 10g 10.9g +8.6% 97.80% Lab D
21 May 2026 Retatrutide 30mg Pen Kit 10.0 15mg 15.7mg +4.9% 97.83% Lab D
20 May 2026 APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 8.7 10g 10.8g +8.0% 99.57% Lab E
20 May 2026 Vesugen 6.2 10mg 11.1mg +10.5% 97.02% Lab D
19 May 2026 Andarine S4 8.2 100mg 109.8mg +9.8% 99.13% Lab C
19 May 2026 ARA-290 7.6 20mg 17.9mg -10.4% 95.17% Lab D
19 May 2026 Cagrilintide 5mg + Semaglutide 5mg Blend 6.3 5mg 4.8mg -3.7% 99.66% Lab A
19 May 2026 EPO 7.1 10mg 12.4mg +23.7% 99.02% Lab G
19 May 2026 GW-501516 (Cardarine) 4.1 25mg 22.7mg -9.1% 98.98% Lab A
19 May 2026 IGF-1 LR3 7.5 30mg 33.7mg +12.4% 99.25% Lab A
19 May 2026 L-Carnitine 500mg 8.3 100mg/ml 104.5mg/ml +4.5% 97.89% Lab C
19 May 2026 Primobolan E Raw 6.5 5g 5.5g +10.1% 95.75% Lab B
17 May 2026 ACE-031 8.8 2mg 2.4mg +20.7% 96.94% Lab F
17 May 2026 AHK-CU 9.1 20mg 22.4mg +11.9% 96.03% Lab B
17 May 2026 ARA-290 5.7 20mg 23.4mg +16.8% 98.23% Lab E
17 May 2026 SNAP-8 7.8 20mg 20.2mg +1.2% 99.03% Lab F
29 Jan 2026 AHK-CU 7.2 5mg 6.2mg +24.8% 99.00% Lab F
29 Jan 2026 Anastrozole (Arimidex) Raw 8.2 500g 596.9g +19.4% 99.60% Lab F
29 Jan 2026 IGF-1 LR3 10.0 50mg 50.9mg +1.8% 99.42% Lab B
29 Jan 2026 Pinealon 7.6 30mg 26.2mg -12.8% 97.57% Lab D
29 Jan 2026 Retatrutide 5mg + Cagrilintide 5mg Blend 5.8 20mg 19.3mg -3.6% 99.38% Lab G
29 Jan 2026 SNAP-8 7.3 30mg 27.8mg -7.4% 98.89% Lab B
26 Jan 2026 AHK-CU 6.0 50mg 56.2mg +12.5% 96.72% Lab D
19 Jan 2026 ACE-031 4.4 2mg 1.7mg -14.7% 97.83% Lab G
19 Jan 2026 Anastrozole (Arimidex) Raw 7.0 10g 10.1g +1.1% 96.77% Lab F
19 Jan 2026 Anastrozole (Arimidex) Raw 6.7 1g 1.2g +19.0% 97.37% Lab C
19 Jan 2026 Cagrilintide 5mg + Semaglutide 5mg Blend 8.8 50mg 52.7mg +5.4% 99.35% Lab F
9 Jan 2026 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 7.9 5g 5.1g +1.6% 97.45% Lab D
9 Jan 2026 ACE-031 8.5 5mg 4.8mg -4.1% 95.38% Lab A
9 Jan 2026 Andarine S4 9.9 50mg 42.6mg -14.7% 96.87% Lab G
9 Jan 2026 EPO 7.0 20mg 19.9mg -0.3% 96.32% Lab F
9 Jan 2026 IGF-1 LR3 6.7 30mg 26.4mg -11.9% 95.10% Lab A
9 Jan 2026 Phenylacetic acid CAS 103-82-2 7.7 500g 607.4g +21.5% 99.71% Lab E
9 Jan 2026 Primobolan E Raw 4.2 100g 122.8g +22.8% 97.74% Lab F
9 Jan 2026 Retatrutide 5mg + Cagrilintide 5mg Blend 7.8 10mg 12.2mg +21.7% 96.04% Lab A
7 Jan 2026 AHK-CU 9.3 15mg 12.8mg -14.9% 98.24% Lab A
7 Jan 2026 Anastrozole (Arimidex) Raw 7.4 100g 112.1g +12.1% 98.14% Lab B
7 Jan 2026 APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 8.6 5g 4.8g -3.9% 98.63% Lab B
7 Jan 2026 Blend 375 (Tren E 125mg+Mast E 125mg+Test E 125mg) 10.0 100mg/ml 88.5mg/ml -11.5% 97.87% Lab E
7 Jan 2026 BPC157 10mg + TB500 10mg Blend 5.4 15mg 17.0mg +13.1% 97.94% Lab D
7 Jan 2026 Cagrilintide 5mg + Semaglutide 5mg Blend 6.5 50mg 52.4mg +4.8% 95.19% Lab F
7 Jan 2026 KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg 9.8 50mg 47.1mg -5.9% 96.89% Lab A
7 Jan 2026 Pinealon 9.7 50mg 43.8mg -12.4% 99.44% Lab B
7 Jan 2026 Pinealon 8.8 20mg 21.4mg +7.2% 98.49% Lab D
7 Jan 2026 SS-31 6.9 20mg 17.5mg -12.7% 97.73% Lab E
6 Jan 2026 ACE-031 8.1 15mg 17.8mg +19.0% 95.85% Lab C
6 Jan 2026 ACE-031 5.7 20mg 20.6mg +3.2% 95.06% Lab B
6 Jan 2026 AHK-CU 8.0 20mg 18.1mg -9.3% 98.73% Lab G
6 Jan 2026 BPC157 10mg + TB500 10mg Blend 8.2 30mg 30.5mg +1.6% 95.67% Lab G
6 Jan 2026 IGF-1 LR3 7.1 2mg 1.8mg -10.2% 97.05% Lab E
6 Jan 2026 KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg 7.6 15mg 13.4mg -10.5% 97.62% Lab B
6 Jan 2026 Phenylacetic acid CAS 103-82-2 6.3 500g 555.2g +11.0% 97.68% Lab D
6 Jan 2026 Retatrutide 30mg Pen Kit 7.7 2mg 2.0mg +1.7% 96.84% Lab D
29 Dec 2025 ACE-031 5.7 15mg 12.8mg -14.7% 99.44% Lab G
29 Dec 2025 Cagrilintide 5mg + Semaglutide 5mg Blend 9.8 20mg 17.9mg -10.5% 99.49% Lab A
29 Dec 2025 Phenylacetic acid CAS 103-82-2 8.7 10g 11.8g +18.2% 95.78% Lab G
29 Dec 2025 PTD-DBM 8.3 10mg 8.8mg -11.7% 97.43% Lab F
29 Dec 2025 PTD-DBM 5.6 10mg 9.4mg -6.2% 98.56% Lab A
12 Dec 2025 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 10.0 100g 101.0g +1.0% 98.55% Lab G
12 Dec 2025 KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg 8.3 15mg 16.4mg +9.5% 96.01% Lab E
12 Dec 2025 PTD-DBM 6.8 10mg 10.1mg +0.9% 96.19% Lab C
12 Dec 2025 Retatrutide 30mg Pen Kit 8.6 15mg 14.3mg -4.6% 96.23% Lab B
12 Dec 2025 Retatrutide 5mg + Cagrilintide 5mg Blend 6.4 10mg 10.0mg +0.1% 99.39% Lab F
12 Dec 2025 S-23 Raw 6.5 100g 86.6g -13.4% 99.61% Lab A
5 Dec 2025 BPC157 10mg + TB500 10mg Blend 9.2 20mg 22.1mg +10.3% 99.23% Lab G
5 Dec 2025 Primobolan E Raw 8.3 10g 10.8g +8.0% 99.73% Lab E
5 Dec 2025 Retatrutide 5mg + Cagrilintide 5mg Blend 5.3 15mg 15.1mg +0.4% 98.74% Lab G
5 Dec 2025 Vesugen 7.9 30mg 30.4mg +1.2% 99.43% Lab A
5 Dec 2025 Vesugen 7.4 10mg 11.7mg +16.6% 98.30% Lab F
23 Nov 2025 Cagrilintide 5mg + Semaglutide 5mg Blend 8.3 5mg 5.5mg +9.5% 98.25% Lab D
23 Nov 2025 KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg 7.4 20mg 17.1mg -14.7% 96.55% Lab E
23 Nov 2025 KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg 7.6 20mg 18.2mg -9.2% 95.71% Lab E
17 Nov 2025 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 7.1 100g 87.2g -12.8% 96.94% Lab D
17 Nov 2025 Cerebrolysin 8.6 15mg 13.7mg -8.8% 99.66% Lab A
17 Nov 2025 Drostanolone Propionate (Mast P) Raw 8.2 5g 6.0g +19.1% 96.48% Lab B
17 Nov 2025 KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg 7.0 50mg 47.1mg -5.8% 95.16% Lab B
17 Nov 2025 Pinealon 9.3 50mg 44.9mg -10.2% 96.79% Lab C
14 Nov 2025 ACE-031 7.7 15mg 15.4mg +2.7% 95.93% Lab G
14 Nov 2025 APAAN (alpha-phenylacetoacetonitrile) CAS 4468-48-8 5.4 500g 437.1g -12.6% 97.55% Lab F
14 Nov 2025 Drostanolone Propionate (Mast P) Raw 8.6 5g 5.2g +4.2% 98.52% Lab A
14 Nov 2025 IGF-1 LR3 6.6 2mg 2.2mg +11.0% 96.22% Lab B
5 Nov 2025 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 7.0 100g 101.2g +1.2% 99.36% Lab F
5 Nov 2025 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 8.5 500g 447.6g -10.5% 99.09% Lab A
5 Nov 2025 Andarine S4 8.8 50mg 58.8mg +17.6% 99.78% Lab E
5 Nov 2025 IGF-1 LR3 7.3 5mg 4.5mg -10.7% 95.17% Lab G
5 Nov 2025 KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg 7.8 20mg 22.9mg +14.4% 98.76% Lab A
5 Nov 2025 SNAP-8 7.9 2mg 2.3mg +17.1% 96.30% Lab C
5 Nov 2025 SS-31 8.1 50mg 44.6mg -10.8% 96.86% Lab C
5 Nov 2025 SS-31 7.0 50mg 61.0mg +22.1% 98.83% Lab E
4 Nov 2025 AHK-CU 7.5 2mg 2.1mg +3.2% 98.30% Lab F
4 Nov 2025 Anastrozole (Arimidex) Raw 9.3 100g 115.3g +15.3% 99.06% Lab G
4 Nov 2025 BPC157 10mg + TB500 10mg Blend 7.9 15mg 15.1mg +0.9% 95.90% Lab E
4 Nov 2025 BPC157 10mg + TB500 10mg Blend 9.0 2mg 1.8mg -8.5% 96.72% Lab D
4 Nov 2025 Drostanolone Propionate (Mast P) Raw 9.3 100g 111.6g +11.6% 97.25% Lab A
4 Nov 2025 Drostanolone Propionate (Mast P) Raw 7.8 5g 5.7g +14.6% 97.67% Lab F
4 Nov 2025 Drostanolone Propionate (Mast P) Raw 7.8 100g 114.4g +14.4% 99.72% Lab B
4 Nov 2025 EPO 7.6 20mg 24.7mg +23.7% 99.11% Lab B
4 Nov 2025 L-Carnitine 500mg 6.4 200mg/ml 196.4mg/ml -1.8% 95.09% Lab D
4 Nov 2025 Primobolan E Raw 7.9 10g 10.5g +4.8% 96.24% Lab G
4 Nov 2025 Retatrutide 30mg Pen Kit 9.1 10mg 9.0mg -10.0% 99.62% Lab C
17 Oct 2025 1-Boc-4-(4-fluorophenylamino)piperidine CAS 288573-56-8 9.1 10g 8.7g -12.9% 95.92% Lab C
17 Oct 2025 Cagrilintide 5mg + Semaglutide 5mg Blend 8.5 30mg 31.1mg +3.6% 97.71% Lab F
17 Oct 2025 Cartalax 8.1 30mg 29.6mg -1.2% 96.91% Lab A
17 Oct 2025 KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg 7.4 20mg 17.7mg -11.6% 96.54% Lab F
17 Oct 2025 MT-1 8.4 50mg 49.5mg -1.1% 97.86% Lab C
17 Oct 2025 Phenylacetic acid CAS 103-82-2 7.8 1g 1.0g -4.0% 95.57% Lab B
9 Oct 2025 Phenylacetic acid CAS 103-82-2 9.0 100g 91.4g -8.6% 95.78% Lab D
9 Oct 2025 PTD-DBM 7.7 15mg 13.5mg -10.0% 99.76% Lab E
9 Oct 2025 Retatrutide 30mg Pen Kit 8.7 20mg 24.1mg +20.6% 99.88% Lab F
9 Oct 2025 SS-31 9.6 10mg 9.8mg -2.1% 95.71% Lab D
3 Oct 2025 Anastrozole (Arimidex) Raw 7.5 500g 495.1g -1.0% 99.00% Lab E
3 Oct 2025 Anastrozole (Arimidex) Raw 8.3 10g 12.4g +24.1% 95.23% Lab D
3 Oct 2025 Cagrilintide 5mg + Semaglutide 5mg Blend 8.7 10mg 11.5mg +14.9% 99.03% Lab D
3 Oct 2025 Cerebrolysin 8.4 50mg 46.6mg -6.8% 97.97% Lab E
3 Oct 2025 MT-1 8.3 50mg 43.4mg -13.2% 95.64% Lab B